NCT06313853Recruiting
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
Source: ClinicalTrials.gov · Last updated 24 Mar 2026
Brief summary (registry, in English)
Building upon prior work, the investigator team developed a communication intervention for older adults with ADRD who are considering a decision about cancer management (adapted intervention: COACH-Cog). The investigators hypothesize that for patients with dual diagnoses of ADRD and cancer, COACH-Cog will increase autonomy support of care partners and patients in the decision-making process, leading to greater acknowledgement and support of cognitive concerns and cognitive-related goals, thereby improving goal concordant care. The investigators are conducting a pilot randomized controlled trial (RCT; cluster randomized by physician) including approximately 45 oncology clinicians and 130 patient/care partner dyads evaluating the effect of COACH-Cog on care partner and patient autonomy support, care partner well-being, goal-concordance, and communication.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 6 Feb 2024
- Start date
- Oct 2024
- Primary completion date
- Apr 2027
- Lead sponsor
- University of Rochester
- Diseases
- Alzheimer disease
- NCT number
- NCT06313853
What you commit to
- Study type: Interventional
- Planned participants: 300
- From Oct 2024 to the primary completion date, Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- PATIENTS:
- Patient Inclusion Criteria:
- Be age 65 or older
- Have a clinical diagnosis of Alzheimer's disease or related dementia (ADRD \[Alzheimer's disease, vascular dementia, Lewy body dementia, frontotemporal dementia, or dementia of unknown subtype\])
- Have a clinical diagnosis of cancer (any type or stage)
- Anticipate a potential decision about cancer-related management, as confirmed by the patient's primary medical oncology clinician.
- Have a care partner willing and able to participate in the study
- Are able to read and understand English. The communication coaching session will be delivered in English, thus necessitating this requirement.
- Be able to provide informed consent (as measured by UBACC) or have a Legally Authorized Representative to provide informed consent
- Patient Exclusion Criteria:
- Patient exclusion criteria: None
- CARE PARTNER:
- Care partner inclusion criteria:
- Age 18 or over
- Able to read and understand spoken English
- Able to provide informed consent
- Care partner exclusion criteria:
- None
- ONCOLOGY CLINICIAN:
- Oncology clinician inclusion criteria:
- Oncology clinicians affiliated with the Wilmot Cancer Institute
- Do not intend to move or retire within the next 2 years.
- Oncology clinician exclusion criteria:
- None
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Rochester Wilmot Cancer Institute Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.